FDA Peptide Review
Peptide News Update: 8/04/2026 During its high-stakes meeting on July 23–24, 2026, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) narrowly voted to recommend adding six out of seven reviewed peptides to the Section 503A Bulk Drug Substances List This historic, narrow vote directly opposed the recommendations of the FDA’s own staff scientists, who warned against […]